NetworkNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Files Q4, Year-End 2023 Financial Results
FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions to address ailments affecting millions worldwide, has filed its audited annual financial results. According to the announcement, the results are for Q4 and the full fiscal year for the period ending Dec. 31, 2023. The company also announced that it had filed accompanying management's discussion and analysis. To view the full press release, visit https://nnw.fm/Cw6Pt About FSD Pharma Inc. FSD is a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment…







